AEON Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 15:24):

Stats
Today's Volume	833 981
Average Volume	70 008.00
Market Cap	61.73M
Next earnings date	( $-0.310 ) 2024-07-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.35
ATR14	$0.0150 (0.93%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-12	Park Seongsoo	Buy	0
2024-04-12	Daewoong Co., Ltd	Buy	0	Senior Secured Convertible Note
2024-04-11	Daewoong Co., Ltd	Buy	0	Senior Secured Convertible Note
2024-03-24	Daewoong Co., Ltd	Buy	0	Senior Secured Convertible Note
2024-03-19	Thunen Shelley B	Buy	16 260	Stock Option

INSIDER POWER
-26.76
Last 75 transactions
Buy: 22 882 487 \| Sell: 44 661 159

Volume Correlation

Long: -0.18 (neutral)

Short: 0.07 (neutral)

Signal:(59.829) Neutral

AEON Biopharma, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AEON Biopharma, Inc. Correlation - Currency/Commodity

0.12
( neutral )

-0.17
( neutral )

0.00
( neutral )

0.04
( neutral )

-0.39
( neutral )

-0.09
( neutral )

AEON Biopharma, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

AEON Biopharma, Inc.

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.